Latest News for: 2039
Edit
Final terms dated 28 March 2025 relating to EUR 30,000,000 3.50% Notes due 3 February 2039 (to be consolidated and form a single series with the Issuer’s outstanding EUR 200,000,000 3.50% Notes due 3 February 2039 issued on 3 February 2014) (CAF - Corporación Andina de Fomento)
Public Technologies 02 Apr 2025
Edit
Vale anuncia encerramento e resultado final das ofertas de aquisição de bonds com vencimento em 2034, 2039 e 2036 (Vale SA)
Public Technologies 25 Mar 2025
) ... The Offers were made upon the terms and subject to the conditions set forth in the offer to purchase dated as of February 24, 2025 ... Treasury Security for that series of Notes as of 11.00 a.m., New York City time, on March 7, 2025 ... and J.P ... Disclaimer.
Edit
Vale announces expiration and final results of cash tender offers for notes due 2034, 2039 and 2036
PR Newswire 25 Mar 2025
Edit
Vale announces expiration and final results of cash tender offers for notes due 2034, 2039 and 2036 (Form 6-K) (Vale SA)
Public Technologies 25 Mar 2025
). Press Release. Vale announces expiration and final results of cash tender offers for notes due 2034, 2039 and 2036 ... Title of Security. CUSIP /. ISIN Nos. Principal Amount Outstanding(1). Acceptance Priority Level ... 6.875% Guaranteed Notes due 2039 ... and J.P.
Edit
Galmed Pharmaceuticals Secures New Patent Grant Extending Aramchol's Patent Protection to 2039, Strengthening Leadership in NASH/MASH Combination Therapy
PR Newswire 20 Mar 2025
Edit
Galmed Pharmaceuticals Secures New Patent Grant Extending Aramchol’s Patent Protection to 2039, Strengthening Leadership in NASH/MASH Combination Therapy (Form 6-K) (Galmed Pharmaceuticals Ltd)
Public Technologies 20 Mar 2025
Galmed Pharmaceuticals Secures New Patent Grant Extending Aramchol's Patent Protection to 2039, Strengthening Leadership in NASH/MASH Combination Therapy.
- 1